Annual report pursuant to Section 13 and 15(d)

Stock Options (Details Narrative)

v3.21.1
Stock Options (Details Narrative) - USD ($)
12 Months Ended
Dec. 23, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Intrinsic value exercise   $ 1,932,000 $ 995,000
Number of stock options granted   2,111,308 2,531,971  
Exercise price of common stock granted   $ 1.35 $ 2.07  
Employees and Consultants [Member]        
Number of stock options granted 1,340,333 2,111,308 2,531,971  
Exercise price of common stock granted $ 1.36 $ 1.35 $ 2.07  
Expiration period   5 years 5 years  
Stock option vesting period   4 years 4 years  
Fair value of stock options grants   $ 2,438,000 $ 4,564,000  
Expense recognized relating to stock options   1,728,000 $ 1,961,000  
Unrecognized stock based compensation expense   $ 4,146,000    
Stock option, description   expected to be recognized as part of operating expense through December 2024    
Fair value before amendment amount $ 32,000      
Stock based compensation expenses 12,000      
Recognized of operating expense $ 20,000